Photo by nci from unsplash
Novel oral anticoagulants (NOACs) are now the mainstay of stroke prevention for non-valvular atrial fibrillation (NVAF). This study aims to identify the trends in anticoagulant (AC) prescribing and patient demographics… Click to show full abstract
Novel oral anticoagulants (NOACs) are now the mainstay of stroke prevention for non-valvular atrial fibrillation (NVAF). This study aims to identify the trends in anticoagulant (AC) prescribing and patient demographics and comorbid conditions that may influence these practices. We performed a
Keywords:
atrial fibrillation;
valvular atrial;
non valvular;
stroke prevention
Journal Title: Journal of the American College of Cardiology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of the American College of Cardiology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!